P. Welsing

First name
P.
Middle name
M.
Last name
Welsing
Gibson-Smith, D., Klop, C., Elders, P. J., Welsing, P. M., van Schoor, N., Leufkens, H. G., et al. (2014). The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010. Osteoporos Int. http://doi.org/10.1007/s00198-014-2799-x
Klop, C., Welsing, P. M., Cooper, C., Harvey, N. C., Elders, P. J., Bijlsma, J. W., et al. (2014). Mortality in British hip fracture patients, 2000-2010: a population-based retrospective cohort study. Bone. http://doi.org/10.1016/j.bone.2014.06.011
Klop, C., Gibson-Smith, D., Elders, P. J., Welsing, P. M., Leufkens, H. G., Harvey, N. C., et al. (2015). Anti-osteoporosis drug prescribing after hip fracture in the UK: 2000-2010. Osteoporos Int. http://doi.org/10.1007/s00198-015-3098-x
Klop, C., de Vries, F., Bijlsma, J. W., Leufkens, H. G., & Welsing, P. M. (2016). Predicting the 10-year risk of hip and major osteoporotic fracture in rheumatoid arthritis and in the general population: an independent validation and update of UK FRAX without bone mineral density. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2015-208958